Berenberg Bank analyst Luisa Hector maintained a Buy rating on Sanofi (SNYNF – Research Report) today and set a price target of €115.00.

In a report released yesterday, Graham Parry from Bank of America Securities maintained a Buy rating on Sanofi (SNYNF – Research Report), ...

The newly merged company also formed a subsidiary known as Sanofi Pasteur, which is today one ... manufacturing and marketing of pharmaceutical products. These products are sold principally ...

Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 15,925.91 Crore) operating in Pharmaceuticals sector. Sanofi India Ltd. key Products/Revenue Segments ...

head of the Sanofi Pasteur vaccines division at the French drugmaker. "Welcoming Origimm within Sanofi expands our area of expertise by bringing extensive know-how in the field of skin microbiome ...

Factors associated with increased flare rates post-vaccination included active disease at the time, female sex, and -- most ...

The French government is looking at options including taking a public stake in the consumer health business that Sanofi is in talks to sell to US buyout firm Clayton Dubilier & Rice to protect ...

Paul Hudson is reshaping Sanofi into a modern healthcare company with the ambition to transform the practice of medicine. Paul and the Sanofi teams are focusing efforts to discover, develop, ...

Sanofi Consumer Healthcare India Limited was incorporated on May 10 2023 pursuant to a Certificate of Incorporation issued by the Registrar of Companies Central Registration Centre. Pursuant to the ...

Natural products are small molecules produced naturally by any organism including primary and secondary metabolites. They include very small molecules, such as urea, and complex structures ...

Q4 and FY 2020 results from Sanofi I am incredibly proud of the measurable progress we made in 2020 even in the face of a global pandemic. We'll stay the course in 2021, focused on bringing ...